OBSTETRICS AND GYNECOLOGY妇产科学

OBSTETRICS AND GYNECOLOGY(英文缩写 OBSTET GYNECOL),ISSN 0029-7844,eISSN 0029-7844,中文译名:妇产科学 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。

2026 年数据 · 影响因子
5.100
JCR 分区
Q1
CAS 分区
B2
近一年发文量
385
本站 PubMed 收录统计

发文量统计区间:2025-11-01 至 2026-10-31,按本站收录文献的发表日期统计。

ISSN: 0029-7844 · eISSN: 0029-7844 · 缩写: OBSTET GYNECOL ·中文: 妇产科学

期刊介绍

选择期刊介绍栏目

期刊简介

《妇产科学》是美国妇产科医师学会的官方期刊,以发表妇产科及相关领域的临床研究、综述和指南而闻名。内容覆盖母胎医学、妇科肿瘤、生殖内分泌、泌尿妇科及普通妇产科,读者群主要是临床医生、住院医师和研究者。该刊注重证据等级和临床可操作性,常刊发能改变实践的研究,在妇产科领域具有较高权威性。

研究方向

主要方向包括产科并发症、产前诊断、妇科良恶性疾病、微创手术、生殖医学、避孕与更年期管理、女性健康流行病学及卫生服务研究。论文类型有原创研究、系统综述、临床指南、述评和病例报告,也接受随机对照试验和大型队列研究。

期刊特色

研究取向偏重临床相关性和方法学严谨性,强调结果对诊疗决策的影响。论文通常结构规范、数据完整,讨论部分注重与现有证据的整合。适合有明确临床问题、能提供高质量数据或系统分析的研究者,也适合关注妇产科前沿进展的临床医生阅读。

投稿难度

投稿难度较高,对创新性、样本量和统计方法要求严格。建议在投稿前明确临床意义,完善研究设计,并参考近期同类文章调整写作。若被拒稿,可根据审稿意见补充分析或转投专科期刊,不宜仅凭分区判断录用可能性。

历年影响因子趋势

JCR 数据年份影响因子JCR 分区
20217.623Q1
20227.200Q1
20235.700Q1
20244.700Q1
20255.100Q1

OBSTETRICS AND GYNECOLOGY 最新收录文献

  1. JCR分区: Q1 CAS分区: B2 影响因子: 5.1
  2. JCR分区: Q1 CAS分区: B2 影响因子: 5.1

    2. In Reply.

    作者:
    Claire Schultz, Nicole Larrea
    日期:
    2026-10-01

    该文献暂无摘要。

  3. JCR分区: Q1 CAS分区: B2 影响因子: 5.1

    3. Intrauterine Balloon Tamponade Duration for Postpartum Hemorrhage: A Randomized Controlled Trial.

    作者:
    Paul Berveiller, Patrick Rozenberg, Paul Guerby, Charles Garabédian
    日期:
    2026-10-01

    该文献暂无摘要。

  4. JCR分区: Q1 CAS分区: B2 影响因子: 5.1
  5. JCR分区: Q1 CAS分区: B2 影响因子: 5.1
  6. JCR分区: Q1 CAS分区: B2 影响因子: 5.1

    6. Improving Pregnancy Outcomes Through Better Prenatal Care Data and Metrics.

    作者:
    Alex F Peahl, Mary Elmore DeMott, Jessica M Yaser, Gregor A Horvath, Elizabeth Bondi-Kelly, Hayley Falk, David M Haas, Chloé E Hill, Julie Simmons Ivy, Elizabeth E Krans, Lisa Kane Low, Michelle H Moniz, Maria Muzik, Julia C Phillippi, Roger D Smith, Shawna Smith, Molly J Stout, Jenna Wiens, Kara Zivin, Giselle E Kolenic
    日期:
    2026-09-29

    Despite the critical importance of prenatal care for the prevention of maternal morbidity in the United States, relatively few resources are dedicated to improving its quality. This omission is driven in part by an absence of detailed prenatal care data: global insurance payments, the dispersion of services across multiple care settings, and a focus on more costly inpatient care delivery have limited our ability to measure and improve prenatal care quality. The upcoming unbundling of prenatal care billing in January 2027 and the changing Centers for Medicare & Medicaid Services requirements for digital quality measures present an important opportunity to improve insights into prenatal care delivery and associated outcomes. In this manuscript, we identify limitations in current prenatal care metrics and data sources (eg, electronic health record data and insurance claims) that must be addressed. We provide a framework to ensure that prenatal care metrics and associated data yield actionable insights to improve health outcomes and the patient experience of care.

  7. JCR分区: Q1 CAS分区: B2 影响因子: 5.1

    7. A Clearer View of the Organizations Directing Obstetrics and Gynecology Graduate Medical Education.

    作者:
    Gabriella Gosman, Amy E Young, Meredith Alston, Laura Huth, Erika Banks, Mary Cameron Tallman, Michael Geria, AnnaMarie Connolly
    日期:
    2026-09-29

    This article explores the purpose and scope of three key organization types in the field of obstetrics and gynecology that guide residency and fellowship training and establish training requirements: 1) the certifying boards, 2) the specialty societies, and 3) the residency and fellowship training program accrediting bodies. Each organization type plays a distinct role in the training, certification, and professional development of obstetricians and gynecologists in the United States. An awareness of these unique roles and scopes is crucial to understanding how these organizations independently and collaboratively work to advance the shared goal of excellence in obstetrics and gynecology graduate medical education and improved health outcomes.

  8. JCR分区: Q1 CAS分区: B2 影响因子: 5.1

    8. Obstetric Care Coding: Time for Change.

    作者:
    Lisa G Hofler, John P Horton, Eilean L Attwood, Lisa Satterfield
    日期:
    2026-09-29

    该文献暂无摘要。

  9. JCR分区: Q1 CAS分区: B2 影响因子: 5.1

    9. Surgical, Reproductive, and Child Developmental Outcomes After 10 Years of Uterus Transplantation in the United States.

    作者:
    Kathleen E O'Neill, Leigh A Humphries, Margaret Rush, Elliott G Richards, Tommaso Falcone, Jessica R Walter, Nawar Latif, Samir Abu-Gazala, Samantha D Fry, Paige M Porrett, Giuliano Testa, Liza Johannesson
    日期:
    2026-09-29

    To review the surgical, reproductive, and child developmental outcomes after uterus transplants performed in the United States over the past decade. In this prospective cohort study, data on donors, recipients, and children born after uterus transplantation were collected at the four centers performing uterus transplants in the United States from February 2016 to December 2025. Interventions included donor hysterectomy, uterus transplantation, postoperative immunosuppression and monitoring, fertility and obstetric care, recipient graft hysterectomy, and neonatal and pediatric follow-up. Survival analyses evaluated trends and compared outcomes between living donor and deceased donor transplants. Among 60 uterus transplants, the most common indication was Mayer-Rokitansky-Küster-Hauser syndrome (n=52), followed by prior hysterectomy (n=6), dysfunctional uterus (n=1), and androgen insensitivity syndrome (n=1). Most transplants (42, 70.0%) involved living donors; 18 (30.0%) involved deceased donors. No life-threatening complications or mortality occurred. Complications necessitating reoperation occurred in 17 of 60 recipients (28.3%), including graft loss attributable to vascular thrombosis, and in 6 of 42 living donors (14.3%), including ureteral injury and vaginal cuff dehiscence. As of December 2025, 42 of 60 recipients (70.0%) had achieved at least one live birth or ongoing clinical pregnancy, and nine (15.0%) had two live births. Among the 48 neonates born, median gestational age at delivery was 36 5/7 weeks (IQR 34 3/7-37 1/7 weeks), with 58.3% born preterm. Neurodevelopment was normal at discharge and 6 months; at 3-year follow-up (n=29), two children had been diagnosed with autism, and no other diagnoses or growth disorders were observed. Uterus transplantation offers a viable path to childbearing for women with absolute uterine factor infertility. These aggregate data from active U.S. programs provide a contemporary reference for clinicians counseling patients on treatment options.

  10. JCR分区: Q1 CAS分区: B2 影响因子: 5.1

    10. Milestones in Motion: Preterm Birth.

    作者:
    Cynthia Gyamfi-Bannerman
    日期:
    2026-09-22

    该文献暂无摘要。

在 OBSTETRICS AND GYNECOLOGY 中搜索更多文献

支持中英文检索 · 智能翻译 · 影响因子 · PDF 下载 · AI 文献阅读

指标接近的期刊